MedPath

The effect of Satureja hortensis L. cream in treatment vulvovaginal candidiasis

Phase 3
Recruiting
Conditions
Candidal vulvovaginitis.
Candidiasis of vulva and vagina
Registration Number
IRCT20180202038591N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
84
Inclusion Criteria

Signs and symptoms of vulvovaginal candidiasis
Positive Gram staining smear
Culture from vaginal discharge

Exclusion Criteria

Age between 18 -45
Being married
Only sexual partner
Signs and symptoms of vulvovaginal candidiasis
Positive Gram staining smear
Culture from vaginal discharge
The absence of any known medical condition
Lack of any allergy to coltriamzol cream and Satureja hortensis L
Completion of written consent form for examination and sampling

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vaginal Discharge. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Clinical Examination, Observation and Medical history.;Itching. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Vulva and Vaginal Burning. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Vaginal discharge culture results. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Vaginal discharge culture.;Compelet remission. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Evauation of clinical symptom's remission and negetive result of vaginal discharge culture.
Secondary Outcome Measures
NameTimeMethod
Dyspareunia. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Side Effects. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Question of patient.
© Copyright 2025. All Rights Reserved by MedPath